is rybelsus a glp 1 drug Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Rybelsus®

Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, et al

Some doctors and specialists may also consider lower BMI thresholds when patients have weight-related conditions, reflecting evidence that Asian populations tend to develop obesity-related metabolic complications including Type 2 diabetes and cardiovascular disease at lower BMI levels than Western populations

However, as this analysis was conducted post hoc, the findings should be interpreted with caution and considered hypothesis-generating rather than evidence of superiority between agents

[3] Not only does GLP-1 affect appetite signaling in key brain regions, potentially helping discourage compulsive eating , it can also have a mechanical effect on your feeling of satiety by delaying gastric emptying

Finaly Thoughts As you can see, there is not a one size fits all approach when it comes to your health

Additionally, while our findings are reassuring with regard to effects on newborn birthweight, we will need to exclude any potential long-term impact on childhood metabolic health. For more information: Jacqueline Maya, MD , can be reached at [email protected].